Citizens lowered the firm’s price target on Bowhead Specialty (BOW) to $38 from $40 and keeps an Outperform rating on the shares. Fourth quarter results are expected to reflect lighter catastrophe losses and limited mark-to-market impacts, with attention focused on pricing trends amid weakness in property lines, the analyst tells investors in a research note. While property pricing is declining, returns remain strong and casualty lines continue to see solid rate increases, pointing to a market in transition rather than broadly soft, the firm says.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Bowhead Specialty price target lowered to $36 from $38 at Keefe Bruyette
- Bowhead Specialty price target raised to $32 from $30 at Piper Sandler
- Bowhead Specialty Secures $35M Credit Facility Agreement
- Bowhead Specialty Completes $150M Senior Notes Offering
- Bowhead Specialty resumed with an Outperform at RBC Capital
